5 studies found for: "hutchinson-gilford progeria syndrome"
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
Clinical Studies of Progeria
Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
† Indicates status has not been verified in more than two years